These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. Rx for addiction. Holloway M Sci Am; 1991 Mar; 264(3):94-103. PubMed ID: 1675486 [No Abstract] [Full Text] [Related]
64. Regulation of glutathione and cell toxicity following exposure to neurotropic substances and human immunodeficiency virus-1 in vitro. Koutsilieri E; Götz ME; Sopper S; Sauer U; Demuth M; ter Meulen V; Riederer P J Neurovirol; 1997 Oct; 3(5):342-9. PubMed ID: 9372455 [TBL] [Abstract][Full Text] [Related]
65. Dopamine action and metabolism in the kidney. Aperia A Curr Opin Nephrol Hypertens; 1994 Jan; 3(1):39-45. PubMed ID: 7850410 [TBL] [Abstract][Full Text] [Related]
66. Classic Studies on the Interaction of Cocaine and the Dopamine Transporter. Verma V Clin Psychopharmacol Neurosci; 2015 Dec; 13(3):227-38. PubMed ID: 26598579 [TBL] [Abstract][Full Text] [Related]
67. Role of transport proteins in drug discovery and development: a pharmaceutical perspective. Ayrton A; Morgan P Xenobiotica; 2008 Jul; 38(7-8):676-708. PubMed ID: 18668427 [TBL] [Abstract][Full Text] [Related]
69. The dopamine transporter: importance in Parkinson's disease. Nutt JG; Carter JH; Sexton GJ Ann Neurol; 2004 Jun; 55(6):766-73. PubMed ID: 15174010 [TBL] [Abstract][Full Text] [Related]
70. ADHD and the dopamine transporter: are there reasons to pay attention? Mazei-Robinson MS; Blakely RD Handb Exp Pharmacol; 2006; (175):373-415. PubMed ID: 16722244 [TBL] [Abstract][Full Text] [Related]
71. X-ray structure of dopamine transporter elucidates antidepressant mechanism. Penmatsa A; Wang KH; Gouaux E Nature; 2013 Nov; 503(7474):85-90. PubMed ID: 24037379 [TBL] [Abstract][Full Text] [Related]
72. The dopamine transporter and attention-deficit/hyperactivity disorder. Madras BK; Miller GM; Fischman AJ Biol Psychiatry; 2005 Jun; 57(11):1397-409. PubMed ID: 15950014 [TBL] [Abstract][Full Text] [Related]
73. The structure and function of the dopamine transporter and its role in CNS diseases. McHugh PC; Buckley DA Vitam Horm; 2015; 98():339-69. PubMed ID: 25817874 [TBL] [Abstract][Full Text] [Related]
77. The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression. Fuke S; Suo S; Takahashi N; Koike H; Sasagawa N; Ishiura S Pharmacogenomics J; 2001; 1(2):152-6. PubMed ID: 11911442 [TBL] [Abstract][Full Text] [Related]
78. Association between the dopamine transporter gene (DAT1) and attention deficit hyperactivity disorder-related traits in healthy adults. Jeong SH; Choi KS; Lee KY; Kim EJ; Kim YS; Joo EJ Psychiatr Genet; 2015 Jun; 25(3):119-26. PubMed ID: 25915480 [TBL] [Abstract][Full Text] [Related]
79. The binding sites for cocaine and dopamine in the dopamine transporter overlap. Beuming T; Kniazeff J; Bergmann ML; Shi L; Gracia L; Raniszewska K; Newman AH; Javitch JA; Weinstein H; Gether U; Loland CJ Nat Neurosci; 2008 Jul; 11(7):780-9. PubMed ID: 18568020 [TBL] [Abstract][Full Text] [Related]
80. Rapid, complete and large-scale generation of post-mitotic neurons from the human LUHMES cell line. Scholz D; Pöltl D; Genewsky A; Weng M; Waldmann T; Schildknecht S; Leist M J Neurochem; 2011 Dec; 119(5):957-71. PubMed ID: 21434924 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]